Topical Dutasteride for Androgenic Alopecia: Current State and Prospects

The document reviews the potential of topical dutasteride as a treatment for androgenic alopecia, a condition affecting 80% of men and 50% of women. While oral dutasteride is effective, it can cause severe sexual and neurological side effects, prompting interest in localized treatments to minimize systemic absorption. The review highlights the exploration of dutasteride-loaded nanocarriers targeting hair follicles as a promising approach. However, many studies lack adequate controls, and the development of a safe and effective commercial product remains challenging. The research is in its early stages, with future efforts suggested to focus on larger nanocarriers, around 600 nm, for better follicular targeting.